Episodes (Page 11)
✨
Charles River CSO advocates for non-animal testing models.
Julie Frearson
✨
PAGB promotes digital health for Self-Care Week.
Michelle Riddalls
✨
PAGB promotes Rx-to-OTC switch for growth.
Michelle Riddalls
✨
BCIs surge ahead with funding and trials.
Brian Bossetta
Elizabeth Orr
Marion Webb
Shubham Singh
✨
Expert panel discusses 2026 life sciences trends.
✨
Biotech IPOs show signs of recovery.
Arda Ural
✨
ESMO 2025 highlights exciting oncology data.
✨
Pfizer pursues Metsera acquisition; Lilly shows obesity momentum.
✨
Pfizer continues pursuit of Metsera acquisition.
✨
George Tidmarsh departs as head of FDA's drug center.
George Tidmarsh
✨
Next-generation immuno-oncology strategies are explored.
Izabela Chmielewska
Sarah Anderson
✨
Q3 dealmaking shows signs of recovery.
✨
Third quarter dealmaking activity increases.
✨
FDA streamlines biosimilar development requirements.
✨
Venture capital challenges and considerations for Korean biotech funding.
✨
Discussion on the future of dealmaking in the obesity market.
Arda Ural
Robert Darwin
✨
AI foundation models are revolutionizing cell therapy development.
Micha Breakstone
Samantha Dale Strasser
✨
Key biopharma news from the week ending Oct 24, 2025.
✨
Biopharma news roundup for the week ending Oct 24, 2025.
✨
FDA inspection group undergoes 'Simple Reform' to move away from specialized teams.